CHU de Grenoble - Hôpital Nord

Grenoble 38043

0 studies enrolling now · 3 studies all time

What they study most

Advanced BRAFV600 Wild-type Melanoma, Biliary Tract Cancer, Ulcerative Colitis

Studies at this site

• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis — Completed
• Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer — Stopped early
• A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma — Stopped early